Netherlands Intravenous Solutions Market Overview, 2030

The Netherlands intravenous (IV) solutions market has seen remarkable evolution. What began as simple saline and dextrose in glass bottles has transformed into intelligent, pre?mixed, multi?chamber bags with vitamins, lipids, and electrolytes. Over the past 10–20 years, product design shifted to closed?system plastics, non?PVC materials, and digital infusion pumps. COVID-19 intensified demand caused short-term supply constraints, but permanently shifted procurement behavior toward online, resilient supply chains, and home infusion adoption. Pandemic-driven demand and supply constraints reinforced the need for redundancy and local manufacturing. Inflation and rural?urban disparity affect affordability and access. As urban healthcare infrastructure develops, rural areas lag behind until governments subsidize hospital procurement or health insurance schemes. Nutrient composition breakdown carbohydrates for hydration, amino acids, lipids, vitamins, minerals, and trace elements fill therapeutic roles. Substitutes include oral/enteral nutrition or rapid delivery injections where permitted, but IV remains essential in critical care. Chronic illnesses like cancer, diabetes, renal disorders, and cardiovascular diseases are rising steadily, pushing hospitals and clinics to expand infusion services. Hospitals and homecare providers now use smart infusion pumps that control dosage and flow rates with minimal manual intervention, reducing error rates and nursing workload. Portable infusion pumps support ambulatory care and are gaining popularity in post-discharge recovery. Home infusion, combined with remote patient monitoring, is expanding through telehealth platforms, especially for long-term antibiotic therapy and parenteral nutrition. This shift reduces hospital stays and improves patient convenience. Eco-conscious hospitals prefer recyclable and reduced-waste packaging. This opens room for IV solution brands that offer biodegradable pouches, compact bag designs, and reduced-plastic secondary packaging. Manufacturers that align with green procurement policies of hospitals gain an edge. Tech innovations included AI-assisted compounding and smart monitoring. Industry consolidation continued with Baxter’s purchase of Hillrom and ICU’s buyout of Smiths Medical. Connected care models where infusion delivery links with smart diagnostics, cloud-based monitoring, and wearable sensors are also expanding.

Tech innovations included AI-assisted compounding and smart monitoring. Industry consolidation continued with Baxter’s purchase of Hillrom and ICU’s buyout of Smiths Medical. Connected care models where infusion delivery links with smart diagnostics, cloud-based monitoring, and wearable sensors are also expanding. Online channels have emerged as the dominant sales route for IV solutions. B2B portals, direct-to-consumer (D2C) manufacturer platforms, and medical e?commerce portals now handle a majority of hospital, pharmacy, and home health orders. These platforms offer bulk ordering, transparency, and fast delivery. While offline channels such as distributor networks and hospital tenders remain useful in rural and institutional settings, online growth continues to outpace them by more than 18% year-over-year. Fluctuations stem from raw material costs (amino acids, lipids, film), packaging innovations, and currency swings. Manufacturers use cost-plus pricing for tenders, value-based pricing for specialized formulations, and offer volume discounts for bulk contracts. Seasonal factors like disease outbreaks and summer hydration spikes also drive occasional price shifts. Major market players like Baxter, Fresenius Kabi, B.?Braun, ICU Medical, Pfizer, Otsuka compete through R&D like smart pumps, multi?chamber bags, non?PVC materials, strategic mergers of Hillrom, Smiths Medical, and localized production. In the past five years, over 80 regional manufacturers entered Latin America, Asia, and Africa, focusing on generics. They face barriers such as capital requirement, regulatory approvals, and procurement trust from hospitals. Incumbents responded via acquisitions, price offers, and toggling between basic and premium products.

Total Parenteral Nutrition represents the more extensive and critical segment, designed to provide complete nutritional support intravenously to patients who cannot meet their dietary requirements through oral or enteral feeding due to conditions such as severe gastrointestinal disorders, major surgeries, critical illnesses, or malabsorption syndromes. TPN solutions are typically highly concentrated and administered via central venous catheters, delivering a carefully balanced mix of macronutrients and micronutrients to sustain metabolism and promote recovery. The rising prevalence of chronic diseases, increasing number of surgical procedures, and enhanced awareness of clinical nutrition benefits are key drivers of TPN demand globally. On the other hand, Peripheral Parenteral Nutrition serves patients with moderate nutritional deficiencies or those needing short-term supplementation. PPN formulations are less concentrated, allowing administration through peripheral veins, which makes it less invasive and more convenient, particularly in outpatient or less intensive care settings. Although PPN occupies a smaller market share due to limitations in osmolarity and duration of use, its ease of administration and lower cost make it a popular choice in various regions. Healthcare infrastructure improvements, growing geriatric populations, and expanding critical care facilities across countries are fueling the adoption of both TPN and PPN. Despite regional differences in healthcare accessibility and reimbursement policies, the global intravenous nutrition market is expected to grow steadily as advances in clinical practices, formulation technologies, and personalized nutrition therapies continue to improve patient outcomes and broaden market reach.

Intravenous nutrition products globally are formulated with a balanced composition of carbohydrates, vitamins and minerals, single-dose amino acids, parenteral lipid emulsions, and other essential components, tailored to meet diverse patient needs across clinical settings. Carbohydrates, primarily supplied as dextrose or glucose, provide the main energy source necessary for maintaining metabolic functions and preventing muscle catabolism during nutritional deprivation. Vitamins and minerals are vital micronutrients incorporated to support enzymatic reactions, immune function, and physiological balance; these include both water-soluble and fat-soluble vitamins, along with essential minerals such as calcium, magnesium, potassium, and phosphorus. Single-dose amino acids offer the fundamental building blocks for protein synthesis, tissue repair, and immune system support, particularly critical for patients with increased metabolic demands or compromised gastrointestinal absorption. Parenteral lipid emulsions provide a concentrated source of calories and essential fatty acids, supporting cell membrane integrity, inflammatory response regulation, and long-term energy needs; these emulsions are commonly derived from vegetable oils such as soybean, olive, or fish oil, formulated to optimize tolerance and reduce side effects. The “others” category encompasses trace elements like zinc, copper, selenium, and electrolytes such as sodium and chloride, which are essential for maintaining fluid-electrolyte balance, nerve conduction, and enzymatic processes. Globally, intravenous nutrition formulations are increasingly personalized to align with clinical guidelines and individual patient requirements, leveraging pharmaceutical advancements to improve safety and efficacy. This comprehensive composition ensures that intravenous nutrition remains a vital therapeutic modality, enhancing recovery and quality of life for patients unable to meet their nutritional needs through conventional feeding methods.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030



Aspects covered in this report
• Intravenous Solutions Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

By Composition
• Carbohydrates
• Vitamins and Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.